BIOTECHNOLOGY AND HEALTH

ETHICAL CHALLENGES FOR INDIA

Authors

  • Mario Vaz DHARMARAM VIDHYA KSHETRAM (DVK)

Keywords:

BIOTECHNOLOGY, HEALTH, ETHICAL CHALLENGES

Abstract

There is no universally accepted definition for the term
Biotechnology. In this paper, I will refer to it in a fairly broad way as
outlined by the UN Convention on Biological Diversity, which
referred to the term as “any technological application that uses
biological systems, living organisms, or derivatives thereof, to make
or modify products or processes for specific use.”1 An alternative
definition, also broad, which lends itself to more easy interpretation
is “the processes and products (usually of industrial scale) offering
the potential to alter and, to a degree, to control the phenomena of
life—in plants, in (non-human) animals, and, increasingly, in human
beings.”2 The second definition goes on to explain some terms more
explicitly by giving examples of the processes (e.g. recombining
genes) and products (e.g. new drugs or vaccines).

Author Biography

Mario Vaz, DHARMARAM VIDHYA KSHETRAM (DVK)

Dr Mario Vaz, MBBS, MD is Professor in the Department of Physiology, St John’s
Medical College, Bangalore. He is also the Head of the Humanities and Health of St
John’s Research Institute, Bangalore. He has conducted a number of research projects
and co-authored over 135 research articles. He has also published a number of
articles/chapters in many edited volumes. 

References

Convention on Biological Diversity. Article 2. Use of Terms. http://www.cbd.int/convention/articles/default.shtml?a=cbd-02.

“Beyond Therapy. Biotechnology and the Pursuit of Happiness.” A Report of the President’s Council on Bioethics, Washington D.C., October, 2003, 2. www.bioethics.gov.

P.M. Bhargava, “The Social, Moral, Ethical, Legal and Political Implications of Today’s Biological Technologies: An Indian Point of View,” Biotechnology Journal 1

(2006).

L. Zhenzhen, Z. Jiuchun, W Ke, H. Thorsteinsdóttir, U. Quach, P.A. Singer, A.S. Daar, “Health Biotechnology in China: Reawakening of a Giant,” Nature Biotechnology 22 (2004, Supplement: DC).

H. Thorsteinsdóttir, A.S. Daar, P.A. Singer, “Health Biotechnology Publishing Takes-off in Developing Countries,” Int. J. Biotechnology 8 (2006).

The Universal Declaration on the Human Genome and Human Rights, 11 November 1997 http://portal.unesco.org/en/ev.php-URL_ID=13177&URL_DO= DO_TOPIC&URL_SECTION=201.html.

A. Robinson, “Ethicists Race to Keep Pace with Advances in Biotechnology,” Canadian Medical Association Journal 167.

Brothers KB, “Ethical Issues in Pediatric Pharmacogenomics,” The Journal of Pediatric Pharmacology and Therapeutics 18, 3 (2013).

A.E. Aiello, N.B. King, B. Foxman, “Ethical Conflicts in Public Health Research and Practice: Antimicrobial Resistance and the Ethics of Drug Development,” Am J

Public Health 96, 11 (November 2006).

J.C. Polkinghorne, “Trends in Biotechnology,” Nr. 18 1/00 http://www. genethik.de/ethical.htm accessed Sept 2, 2013.

A. Liras, “Future Research and Therapeutic Applications of Human Stem Cells: General, Regulatory, and Bioethical Aspects,” Journal of Translational Medicine 8

(December 10, 2010) 131. doi: 10.1186/1479-5876-8-131.

I.M. Verma, “Germline Gene Therapy: Yes or No?,” Mol Ther. 4, 1 (2001).

M.H.B. Schermer, “Brave New World Versus Island—Utopian and Dystopian Views on Psychopharmacology,” Med Health Care Philos 10, 2 (June 2007).

J.A. Roberston, “Reproductive Liberty and the Right to Clone Human Beings,” in Medical Ethics at the Dawn of the 21st Century, Annals of the New York Academy of Sciences, Vol 913, ed., R. Cohen-Almagor.

J. Harris, “Clones, Genes, and Reproductive Autonomy. The Ethics of Human Cloning,” Medical Ethics at the Dawn of the 21st Century.

F. Coeytaux, M. Darnovsky, S.B. Fogel, “Editorial: Contraception: Assisted Reproduction and Choice in the Biotech Age: Recommendations for a Way Forward,” 83 (2011).

Dignitas Personae.

“Genetically Modified Crops: The Ethical and Social Issues,” Nuffield Council on Bioethics, http://www.nuffieldbioethics.org/sites/default/files/GM%20crops %20-

%20full%20report.pdf.

P. Crooks, “The New Eugenics? The Ethics of Biotechnology,” Australian Journal of Politics and History 54 (2008).

M.R. McLean, “A Framework for Thinking Ethically about Biotechnology,” http://www.scu.edu/ethics/publications/submitted/mclean/biotechframework.ht

ml; Accessed Sept 2, 2013.

D. Rajaraman, N. Jesuraj, L. Geiter, S. Bennett, H.M. Grewal, M. Vaz, “Study Group TB,” BMC Med Ethics 12, 1 (February 15, 2011).

S.R. Benatar, A.S. Daar, P.A. Singer, “Global Health Ethics: The Rationale for Mutual Caring,” International Affairs 79 (2003).

H.A. ten Have, “Genetic Advances Require Comprehensive Bioethical Debate,” Croatian Medical Journal 44 (2003).

Francesco Francioni, “Genetic Resources, Biotechnology and Human Rights: The International Legal Framework,” EUI Working Papers LAW, No. 2006/17, http://www.iue.it/.

H. Secara, “Biotechnology and Health Care. Regulations, Limits, Controversies,” 5th International Focus Programme Essay Competition, http://www.coe.int/T/DGHL/Monitoring/SocialCharter/Activities/FocusEssayW innerSecara2013_en.pdf.

T. Acharya, N.K. Kumar, V. Muthuswamy, A.S. Daar, P.A. Singer, “Harnessing Genomics to Improve Health in India: An Executive Course to Support Genomics

Policy,” Health Research Policy and Systems 2, 1 (2004), http://www.health-policysystems. com/content/2/1/1.

T. Kievits, D. Niese, L. Tengbjerg Hansen, P. Collins, S. Le Gledic, A. Roediger, A. Heathfield, A. Hallersten, “Personalised Medicine: Status quo and Challenges,”

EuropaBio, http://www.europabio.org/sites/default/files/report/personalised_ medicine_status_quo_and_challenges.pdf.

Universal Declaration on the Human Genome and Human Rights. http://portal.unesco.org/en/ev.php-URL_ID=13177&URL_DO=DO_TOPIC& URL_SECTION=201.html accessed Sept 2, 2013.

The International Declaration on Human Genetic Data http://portal.unesco.org/en/ev.php-URL_ID=17720&URL_DO=DO_TOPIC& URL_SECTION=201.html.

Universal Declaration on Bioethics and Human Rights. http://portal.unesco.org/en/ev.php-URL_ID=31058&URL_DO=DO_TOPIC& URL_SECTION=201.html.

http://cdsco.nic.in/CDSCO-GuidanceForIndustry.pdf.

http://icmr.nic.in/ethical_guidelines.pdf.

THE BIOTECHNOLOGY REGULATORY AUTHORITY OF INDIA BILL, 2013. http://www.prsindia.org/uploads/media/Biotech%20Regulatory/Biotechnology%

Regulatory%20Authority%20of%20India%20Bill.pdf

Policy Brief for Parliamentarians. THE BIOTECHNOLOGY REGULATORY AUTHORITY OF INDIA (BRAI) Bill 2013. A threat to our Food and Farming! Policy brief series: No. 19; 2013 June-August.

BRAI Bill, 2013 - India’s Monsanto Promotion and Protection Act. http://www.greenpeace.org/india/Global/india/docs/BRAI-Monsantobriefing. pdf.

Francesco Francioni, “Genetic Resources, Biotechnology and Human Rights,” 8.

S.R. Benatar, A.S. Daar, P.A. Singer, “Global Health Ethics.”

Downloads

Published

2013-12-31

How to Cite

Vaz, M. (2013). BIOTECHNOLOGY AND HEALTH: ETHICAL CHALLENGES FOR INDIA. Asian Horizons, 7(04), 667–682. Retrieved from https://dvkjournals.in/index.php/ah/article/view/2637